BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10567719)

  • 1. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes.
    Nagase I; Yoshida S; Canas X; Irie Y; Kimura K; Yoshida T; Saito M
    FEBS Lett; 1999 Nov; 461(3):319-22. PubMed ID: 10567719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of uncoupling proteins by beta-adrenergic stimulation in L6 myotubes.
    Nagase I; Yoshida T; Saito M
    FEBS Lett; 2001 Apr; 494(3):175-80. PubMed ID: 11311236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of uncoupling protein-2 mRNA in L6 myotubules: II: Thyroid hormone amplifies stimulation of uncoupling protein-2 gene by thiazolidinediones and other peroxisome proliferator-activated receptor ligands in L6 myotubules: evidence for a priming effect.
    López-Solache I; Marie V; Camirand A; Silva JE
    Endocrine; 2002 Nov; 19(2):209-17. PubMed ID: 12588052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of uncoupling protein-2 gene expression in L6 myotubes.
    Hatakeyama Y; Scarpace PJ
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1619-24. PubMed ID: 11753581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes.
    Cabrero A; Alegret M; Sánchez RM; Adzet T; Laguna JC; Vázquez M
    FEBS Lett; 2000 Oct; 484(1):37-42. PubMed ID: 11056218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
    Mehta RG; Williamson E; Patel MK; Koeffler HP
    J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.
    Kim HI; Kim JW; Kim SH; Cha JY; Kim KS; Ahn YH
    Diabetes; 2000 Sep; 49(9):1517-24. PubMed ID: 10969836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
    Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
    Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UCP3 gene expression does not correlate with muscle oxidation rates in troglitazone-treated Zucker fatty rats.
    Oberkofler H; Neschen S; Esterbauer H; Waldhäusl W; Patsch W; Fürnsinn C
    Biochim Biophys Acta; 2000 Dec; 1517(1):113-8. PubMed ID: 11118623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
    Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
    Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene.
    Pedraza N; Solanes G; Carmona MC; Iglesias R; Viñas O; Mampel T; Vazquez M; Giralt M; Villarroya F
    Diabetes; 2000 Jul; 49(7):1224-30. PubMed ID: 10909982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene.
    Frohnert BI; Hui TY; Bernlohr DA
    J Biol Chem; 1999 Feb; 274(7):3970-7. PubMed ID: 9933587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
    Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
    Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes.
    Son C; Hosoda K; Matsuda J; Fujikura J; Yonemitsu S; Iwakura H; Masuzaki H; Ogawa Y; Hayashi T; Itoh H; Nishimura H; Inoue G; Yoshimasa Y; Yamori Y; Nakao K
    Endocrinology; 2001 Oct; 142(10):4189-94. PubMed ID: 11564673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
    Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential 3,5,3'-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of Fatty acids.
    de Lange P; Feola A; Ragni M; Senese R; Moreno M; Lombardi A; Silvestri E; Amat R; Villarroya F; Goglia F; Lanni A
    Endocrinology; 2007 Aug; 148(8):4064-72. PubMed ID: 17478558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.